Serious adverse events of interest according to anthelminthic drug exposure.

<p>Serious adverse events of interest according to anthelminthic drug exposure.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Pamella Modingam (20135953) (author)
مؤلفون آخرون:	Jean-Luc Faillie (10676094) (author), Jérémy T. Campillo (10676091) (author)
منشور في:	2024
الموضوعات:	Biochemistry Medicine Cell Biology Pharmacology Biotechnology Developmental Biology Cancer Science Policy Mental Health Infectious Diseases Chemical Sciences not elsewhere classified potential confounding factors intestinal parasitosis treatment imputed missing data conducted using data bone marrow failure 71 ]), hepatitis 64 &# 8211 59 &# 8211 36 &# 8211 29 &# 8211 2000 &# 8211 01 &# 8211 reporting odds ratios assess disproportionate reporting hepatic adverse events secondary analysis revealed benzimidazole derivatives use benzimidazole derivatives compared serious adverse reactions adjusted ror 9 serious adverse events significant disproportionality signals adverse events benzimidazole derivatives disproportionality analysis serious urticaria serious hematological sensitivity analysis icsrs reporting xlink "> vigilant monitoring vigibase database study aims product characteristics pharmacoepidemiologic studies new signal mass campaigns hypoplastic anemia findings underscore confidence intervals ci 1 anthelmintic drugs also highlighted 99 ). 2023 ).
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة